Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)

Rapid Fire Moderator(s)

• 

  Hardik Mody, PhD

  Principal Scientist
  Johnson and Johnson
  Collegeville, Pennsylvania

Presentations:

• 3:00 PM – 3:15 PM ET

  Clinical Pharmacology in COVID-19 Drug Development: Remaining Agile During a Public Health Emergency
  

  Rapid Fire Speaker: Kellie S. Reynolds, PharmD – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA
• 3:15 PM – 3:30 PM ET

  Drug Interactions with Paxlovid
  

  Rapid Fire Speaker: Bharat Damle, PhD – Pfizer
• 3:30 PM – 3:45 PM ET

  Challenges in Dose Adjustment for a SARS COV-2 Variant Based on in-vitro Neutralization Data
  

  Rapid Fire Speaker: Kenneth Turner, PhD – Regeneron Pharmaceuticals
• 3:45 PM – 4:00 PM ET

  Rethinking the Role of Clinical Pharmacology in a Systems Perspective to Accelerate Biologics (mAbs, Cytokine Modulator) Development
  

  Rapid Fire Speaker: Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH